1. Surface profiles of live colorectal cancer cells and tumor infiltrating lymphocytes from surgical samples correspond to prognostic categories
- Author
-
Nicola J. Armstrong, Michael J. Solomon, Kimberley L. Kaufman, Richard I. Christopherson, Stephen Clarke, Larissa Belov, Jerry Zhou, Charles Chan, and Pierre H. Chapuis
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Antibody microarray ,Colorectal cancer ,Immunology ,Epitopes, T-Lymphocyte ,chemical and pharmacologic phenomena ,Lymphocytes, Tumor-Infiltrating ,Antigen ,Antigens, CD ,Humans ,Immunology and Allergy ,Medicine ,IL-2 receptor ,Aged ,biology ,business.industry ,CD24 ,Tumor-infiltrating lymphocytes ,hemic and immune systems ,HLA-DR Antigens ,Prognosis ,medicine.disease ,digestive system diseases ,biology.protein ,Cancer research ,Female ,CA19-9 ,Neoplasm Recurrence, Local ,Antibody ,Colorectal Neoplasms ,business - Abstract
Extensive surface profiles of colorectal cancer (CRC) cells and tumor infiltrating lymphocytes (TIL) have been obtained from 45 surgical resection samples. Live cells were captured on an antibody microarray and stained with fluorescently-labeled antibodies. Minimal panels of 11 CRC antigens (CD13, CD24, CD26, CD49d, CD138, CD166, CA-125, CA19-9, EGFR, Galectin-4 and HLA-DR) and 11 T-cell antigens (CD10, CD11b, CD11c, CD25, CD31, CD95, CD151, CD181, Galectin-4, CA19-9, TSP-1) provide signatures for relapse and survival. Hierarchical clustering of profiles from CRC cells and TIL identified groups of patients for survival, systemic relapse and death. The groups from CRC and TIL profiles for systemic relapse showed 79.2% concordance, enabling prediction of relapse after surgery. The results demonstrate communication between CRC cells and TIL.
- Published
- 2015
- Full Text
- View/download PDF